Abstract:Most sedatives inhibit the function of immune system of the body, and it is closely related to the perioperative infections, tumor metastasis and recurrence. Dexmedetomidine (Dex), as a ɑ2 receptor agonist, due to its effects on the immune system, it has unique clinical advantages in perioperative, sepsis, tumor and other patients. This article reviews the research progress of Dex on the innate immunity and specific immune response of the experimental animals and clinical researches in the past 10 years, including the effects on macrophages, dendritic cells, NK cells, inflammatory cytokines, complement and some antibodies.